Gene · 2115
Papers2,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ETV1 orchestrates a self-reinforcing ERK1/2-RSK3 signaling loop to drive atrial fibrillation pathogenesis: implications for targeted therapy. | Sci Rep | 2025 | 41345483 | PubTator, text mining | PubMed |
| Global DNA methylation signatures associated with chemoresistance and poor prognosis of high grade serous ovarian cancer. | Sci Rep | 2025 | 41125735 | PubTator, text mining | PubMed |
| Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology. | J Clin Invest | 2025 | 40956611 | PubTator, text mining | PubMed |
| SUMOylation of the transcription factor Etv1 in cancer stem cells induces tumorigenesis of non-stem cancer cells. | Dev Cell | 2025 | 40925324 | PubTator, text mining | PubMed |
| Transcriptional profiling defines unique subtypes of transit amplifying neural progenitors within the neonatal mouse subventricular zone. | bioRxiv | 2025 | 40901490 | PubTator, text mining | PubMed |
| Transcription factor ETV1 promotes angiogenesis after myocardial infarction via activation of the VEGFA/VEGFR2/eNOS pathway. | Front Cardiovasc Med | 2025 | 40894482 | PubTator, text mining | PubMed |
| SNX7 mediates inhibition of autophagy in prostate cancer via activation of CFLIP expression. | Discov Oncol | 2025 | 40883630 | PubTator, text mining | PubMed |
| High-Resolution aCGH Analysis of the Jurkat Cell Line: Copy Number Alterations and Their Association With Cancer Hallmarks. | Cancer Genomics Proteomics | 2025 | 40883026 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| Screening of hub genes and immunocytes related to tendon injury based on bioinformatics and machine learning models. | Sci Rep | 2025 | 40858849 | PubTator, text mining | PubMed |
| Enhanced NIR-II Nanoparticle Probe for PSMA-Targeted Molecular Imaging and Prostate Cancer Diagnosis. | Int J Nanomedicine | 2025 | 40808713 | PubTator, text mining | PubMed |
| EGFR-STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1-positive prostate cancer. | Mol Oncol | 2025 | 40808640 | PubTator, text mining | PubMed |
| COP1 Deficiency in BRAFV600E Melanomas Confers Resistance to Inhibitors of the MAPK Pathway. | Cells | 2025 | 40643496 | PubTator, text mining | PubMed |
| ETV4 and ETV1-mediated downregulation of the secretory leukocyte protease inhibitor contributes to the indolent phenotype of early-stage prostate cancer. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40633813 | PubTator, text mining | PubMed |
| ETV1 transcriptional manipulation of KIFC1 regulates the progression of pancreatic cancer. | Oncol Res | 2025 | 40612867 | PubTator, text mining | PubMed |
| ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor. | Cancer Chemother Pharmacol | 2025 | 40601091 | PubTator, text mining | PubMed |
| Small modifier, big decision: switching to SUMO mode adds weight to cancer stemness in mammary tumors. | Mol Oncol | 2025 | 40546087 | PubTator, text mining | PubMed |
| Transcription Factors and Coregulators in Schwann Cell Differentiation, Myelination, and Remyelination: Implications for Peripheral Neuropathy. | J Neurosci Res | 2025 | 40452391 | PubTator, text mining | PubMed |
| Single cell transcription revealing key transcription factors in embryonic kidney development. | Mol Cell Biochem | 2025 | 40392427 | PubTator, text mining | PubMed |
| Development and validation of tryptophan metabolism-related risk model and molecular subtypes for predicting postoperative biochemical recurrence in prostate cancer. | Transl Androl Urol | 2025 | 40376539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2115/papers?page=3